Copyright Reports & Markets. All rights reserved.

Global Brucellosis Vaccines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Brucellosis Vaccines Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 S19 Vaccine
    • 1.3.3 RB51 Vaccine Strain
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Brucellosis Vaccines Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Cattle
    • 1.4.3 Sheep
    • 1.4.4 Others
  • 1.5 Global Brucellosis Vaccines Market Size & Forecast
    • 1.5.1 Global Brucellosis Vaccines Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Brucellosis Vaccines Sales Quantity (2020-2031)
    • 1.5.3 Global Brucellosis Vaccines Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Jinyu
    • 2.1.1 Jinyu Details
    • 2.1.2 Jinyu Major Business
    • 2.1.3 Jinyu Brucellosis Vaccines Product and Services
    • 2.1.4 Jinyu Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Jinyu Recent Developments/Updates
  • 2.2 Colorado Serum
    • 2.2.1 Colorado Serum Details
    • 2.2.2 Colorado Serum Major Business
    • 2.2.3 Colorado Serum Brucellosis Vaccines Product and Services
    • 2.2.4 Colorado Serum Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Colorado Serum Recent Developments/Updates
  • 2.3 Boehringer Ingelheim
    • 2.3.1 Boehringer Ingelheim Details
    • 2.3.2 Boehringer Ingelheim Major Business
    • 2.3.3 Boehringer Ingelheim Brucellosis Vaccines Product and Services
    • 2.3.4 Boehringer Ingelheim Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.4 Biogenesis-Bago
    • 2.4.1 Biogenesis-Bago Details
    • 2.4.2 Biogenesis-Bago Major Business
    • 2.4.3 Biogenesis-Bago Brucellosis Vaccines Product and Services
    • 2.4.4 Biogenesis-Bago Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Biogenesis-Bago Recent Developments/Updates
  • 2.5 Vetal Company
    • 2.5.1 Vetal Company Details
    • 2.5.2 Vetal Company Major Business
    • 2.5.3 Vetal Company Brucellosis Vaccines Product and Services
    • 2.5.4 Vetal Company Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Vetal Company Recent Developments/Updates
  • 2.6 CZ Veterinaria
    • 2.6.1 CZ Veterinaria Details
    • 2.6.2 CZ Veterinaria Major Business
    • 2.6.3 CZ Veterinaria Brucellosis Vaccines Product and Services
    • 2.6.4 CZ Veterinaria Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 CZ Veterinaria Recent Developments/Updates
  • 2.7 SYVA Laboratorios
    • 2.7.1 SYVA Laboratorios Details
    • 2.7.2 SYVA Laboratorios Major Business
    • 2.7.3 SYVA Laboratorios Brucellosis Vaccines Product and Services
    • 2.7.4 SYVA Laboratorios Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 SYVA Laboratorios Recent Developments/Updates
  • 2.8 Indian Immunologicals
    • 2.8.1 Indian Immunologicals Details
    • 2.8.2 Indian Immunologicals Major Business
    • 2.8.3 Indian Immunologicals Brucellosis Vaccines Product and Services
    • 2.8.4 Indian Immunologicals Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Indian Immunologicals Recent Developments/Updates
  • 2.9 Qilu
    • 2.9.1 Qilu Details
    • 2.9.2 Qilu Major Business
    • 2.9.3 Qilu Brucellosis Vaccines Product and Services
    • 2.9.4 Qilu Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Qilu Recent Developments/Updates
  • 2.10 Tecnovax
    • 2.10.1 Tecnovax Details
    • 2.10.2 Tecnovax Major Business
    • 2.10.3 Tecnovax Brucellosis Vaccines Product and Services
    • 2.10.4 Tecnovax Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Tecnovax Recent Developments/Updates
  • 2.11 Hester Biosciences
    • 2.11.1 Hester Biosciences Details
    • 2.11.2 Hester Biosciences Major Business
    • 2.11.3 Hester Biosciences Brucellosis Vaccines Product and Services
    • 2.11.4 Hester Biosciences Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Hester Biosciences Recent Developments/Updates
  • 2.12 Zoetis
    • 2.12.1 Zoetis Details
    • 2.12.2 Zoetis Major Business
    • 2.12.3 Zoetis Brucellosis Vaccines Product and Services
    • 2.12.4 Zoetis Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Zoetis Recent Developments/Updates
  • 2.13 Onderstepoort Biological
    • 2.13.1 Onderstepoort Biological Details
    • 2.13.2 Onderstepoort Biological Major Business
    • 2.13.3 Onderstepoort Biological Brucellosis Vaccines Product and Services
    • 2.13.4 Onderstepoort Biological Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Onderstepoort Biological Recent Developments/Updates
  • 2.14 Instituto Rosenbusch
    • 2.14.1 Instituto Rosenbusch Details
    • 2.14.2 Instituto Rosenbusch Major Business
    • 2.14.3 Instituto Rosenbusch Brucellosis Vaccines Product and Services
    • 2.14.4 Instituto Rosenbusch Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Instituto Rosenbusch Recent Developments/Updates
  • 2.15 Ceva Sante Animale
    • 2.15.1 Ceva Sante Animale Details
    • 2.15.2 Ceva Sante Animale Major Business
    • 2.15.3 Ceva Sante Animale Brucellosis Vaccines Product and Services
    • 2.15.4 Ceva Sante Animale Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Ceva Sante Animale Recent Developments/Updates
  • 2.16 Calier & Biologicos Laverlam
    • 2.16.1 Calier & Biologicos Laverlam Details
    • 2.16.2 Calier & Biologicos Laverlam Major Business
    • 2.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Product and Services
    • 2.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Calier & Biologicos Laverlam Recent Developments/Updates
  • 2.17 Biovet
    • 2.17.1 Biovet Details
    • 2.17.2 Biovet Major Business
    • 2.17.3 Biovet Brucellosis Vaccines Product and Services
    • 2.17.4 Biovet Brucellosis Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Biovet Recent Developments/Updates

3 Competitive Environment: Brucellosis Vaccines by Manufacturer

  • 3.1 Global Brucellosis Vaccines Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Brucellosis Vaccines Revenue by Manufacturer (2020-2025)
  • 3.3 Global Brucellosis Vaccines Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Brucellosis Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Brucellosis Vaccines Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Brucellosis Vaccines Manufacturer Market Share in 2024
  • 3.5 Brucellosis Vaccines Market: Overall Company Footprint Analysis
    • 3.5.1 Brucellosis Vaccines Market: Region Footprint
    • 3.5.2 Brucellosis Vaccines Market: Company Product Type Footprint
    • 3.5.3 Brucellosis Vaccines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Brucellosis Vaccines Market Size by Region
    • 4.1.1 Global Brucellosis Vaccines Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Brucellosis Vaccines Consumption Value by Region (2020-2031)
    • 4.1.3 Global Brucellosis Vaccines Average Price by Region (2020-2031)
  • 4.2 North America Brucellosis Vaccines Consumption Value (2020-2031)
  • 4.3 Europe Brucellosis Vaccines Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Brucellosis Vaccines Consumption Value (2020-2031)
  • 4.5 South America Brucellosis Vaccines Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Brucellosis Vaccines Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Brucellosis Vaccines Sales Quantity by Type (2020-2031)
  • 5.2 Global Brucellosis Vaccines Consumption Value by Type (2020-2031)
  • 5.3 Global Brucellosis Vaccines Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Brucellosis Vaccines Sales Quantity by Application (2020-2031)
  • 6.2 Global Brucellosis Vaccines Consumption Value by Application (2020-2031)
  • 6.3 Global Brucellosis Vaccines Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Brucellosis Vaccines Sales Quantity by Type (2020-2031)
  • 7.2 North America Brucellosis Vaccines Sales Quantity by Application (2020-2031)
  • 7.3 North America Brucellosis Vaccines Market Size by Country
    • 7.3.1 North America Brucellosis Vaccines Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Brucellosis Vaccines Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Brucellosis Vaccines Sales Quantity by Type (2020-2031)
  • 8.2 Europe Brucellosis Vaccines Sales Quantity by Application (2020-2031)
  • 8.3 Europe Brucellosis Vaccines Market Size by Country
    • 8.3.1 Europe Brucellosis Vaccines Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Brucellosis Vaccines Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Brucellosis Vaccines Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Brucellosis Vaccines Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Brucellosis Vaccines Market Size by Region
    • 9.3.1 Asia-Pacific Brucellosis Vaccines Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Brucellosis Vaccines Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Brucellosis Vaccines Sales Quantity by Type (2020-2031)
  • 10.2 South America Brucellosis Vaccines Sales Quantity by Application (2020-2031)
  • 10.3 South America Brucellosis Vaccines Market Size by Country
    • 10.3.1 South America Brucellosis Vaccines Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Brucellosis Vaccines Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Brucellosis Vaccines Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Brucellosis Vaccines Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Brucellosis Vaccines Market Size by Country
    • 11.3.1 Middle East & Africa Brucellosis Vaccines Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Brucellosis Vaccines Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Brucellosis Vaccines Market Drivers
  • 12.2 Brucellosis Vaccines Market Restraints
  • 12.3 Brucellosis Vaccines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Brucellosis Vaccines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Brucellosis Vaccines
  • 13.3 Brucellosis Vaccines Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Brucellosis Vaccines Typical Distributors
  • 14.3 Brucellosis Vaccines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Brucellosis Vaccines market size was valued at US$ 12.2 million in 2024 and is forecast to a readjusted size of USD 15.6 million by 2031 with a CAGR of 3.6% during review period.
    Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
    Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.
    This report is a detailed and comprehensive analysis for global Brucellosis Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Brucellosis Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2020-2031
    Global Brucellosis Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2020-2031
    Global Brucellosis Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2020-2031
    Global Brucellosis Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Brucellosis Vaccines
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Brucellosis Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, Vetal Company, CZ Veterinaria, SYVA Laboratorios, Indian Immunologicals, Qilu, Tecnovax, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Brucellosis Vaccines market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    S19 Vaccine
    RB51 Vaccine Strain
    Market segment by Application
    Cattle
    Sheep
    Others
    Major players covered
    Jinyu
    Colorado Serum
    Boehringer Ingelheim
    Biogenesis-Bago
    Vetal Company
    CZ Veterinaria
    SYVA Laboratorios
    Indian Immunologicals
    Qilu
    Tecnovax
    Hester Biosciences
    Zoetis
    Onderstepoort Biological
    Instituto Rosenbusch
    Ceva Sante Animale
    Calier & Biologicos Laverlam
    Biovet
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Brucellosis Vaccines product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Brucellosis Vaccines, with price, sales quantity, revenue, and global market share of Brucellosis Vaccines from 2020 to 2025.
    Chapter 3, the Brucellosis Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Brucellosis Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Brucellosis Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Brucellosis Vaccines.
    Chapter 14 and 15, to describe Brucellosis Vaccines sales channel, distributors, customers, research findings and conclusion.

    Buy now